Long time pick Regeneron $REGN posted positive effect #s in a PNH study. $450 next. $REGN, Regeneron Pharmaceuticals, Inc. / H1 Retailer Michaels $MIK reported a weak outlook. Per SA:For the full year, Michaels expects revenue of $5.06B to $5.08B vs. a prior view for $5.16B to $5.19B and $5.18B consensus. Full-year EPS of $2.07 to $2.12 is anticipated vs. $2.31 to $2.42 prior view and $2.38 consensus.Dollar General $DG posted strong Q3 traffic and SSS increases. $DG, Dollar General Corporation / H1 $ACAD Acadia is up 10% PM on positive pimavanserin data. Buy. $ACAD, ACADIA Pharmaceuticals Inc. / H1 Cdn. banks $TD, $RY reported weak results. $BMO is sadly laying off 5% in an effort to lift efficiency. Sell.Share your trades. Post them in the comments!